Varlitinib
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for Varlitinib, covering 2018-04-17 to 2023-11-13. Get the full timeline:
Most recent: Clinical Trial Update: Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients [Phase 1, Phase 2]